Robert Holtrup
Physician Assistant · Dayton, OHNPI 1669604609
Payments from drug & device makers
Across 199 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$853
- AbbVie$585
- Dexcom, Inc.$276
- Novo Nordisk$245
- Merck$166
- Amgen$158
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,845100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 34 | $853 |
| AbbVie | 36 | $585 |
| Dexcom, Inc. | 10 | $276 |
| Novo Nordisk | 14 | $245 |
| Merck | 9 | $166 |
| Amgen | 8 | $158 |
| Bayer | 8 | $133 |
| GSK | 8 | $120 |
| Pfizer | 7 | $119 |
| Exact Sciences | 6 | $113 |
| Astellas Pharma US Inc | 5 | $110 |
| Cequr Corporation | 2 | $98 |
| Seqirus USA Inc | 5 | $87 |
| Abbott | 4 | $77 |
| Amphastar Pharmaceuticals, Inc. | 4 | $72 |
| Xeris Pharmaceuticals, Inc. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $60 |
| Mylan Specialty L.p. | 3 | $46 |
| Kowa Pharmaceuticals America, Inc. | 3 | $46 |
| Tempus AI, Inc | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $41 |
| Phadia US Inc. | 2 | $39 |
| Mannkind Corporation | 2 | $38 |
| Sanofi Pasteur Inc. | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Ironshore Pharmaceuticals Inc. | 2 | $26 |
| Medtronic | 1 | $26 |
| Genentech USA, Inc. | 2 | $20 |
| Pulmonx Corporation | 1 | $19 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Cranial Technologies, Inc | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,845 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 42 | $31,442 |
| FarxigaDapagliflozin Propanediol | 46 | $27,633 |
| TrulicityDulaglutide | 20 | $27,477 |
| OzempicSemaglutide | 24 | $22,621 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 34 | $21,437 |
| MyrbetriqMirabegron | 35 | $21,229 |
| JanuviaSitagliptin Phosphate | 31 | $18,459 |
| JardianceEmpagliflozin | 24 | $13,560 |
| SymbicortBudesonide/Formoterol Fumarate | 46 | $11,196 |
| RybelsusSemaglutide | 12 | $11,049 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $8,941 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 19 | $8,429 |
| Spiriva RespimatTiotropium Bromide | 14 | $7,555 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 69 | $6,526 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 278 | $6,414 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $853 | $60,266126 claims |
| Novo NordiskOzempic, Rybelsus | $245 | $33,67036 claims |
| PfizerEliquis | $119 | $31,44242 claims |
| Lilly USA, LLCTrulicity | $15 | $27,47720 claims |
| Astellas Pharma US IncMyrbetriq | $110 | $21,22935 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $14 | $21,11538 claims |
| MerckJanuvia | $166 | $18,45931 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $120 | $13,48027 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Dayton
- Emily AnkromDayton$192K
- Mackenzie TideringtonDayton$20K
- Srikanth VangapanduDayton$17K
- Steven WurzelbacherCincinnati$309K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Natalie WalkupSylvania$105K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.